In the EU, national health technology assessment bodies generally aren't so well equipped to address novel and complex medicinal products. That makes the EMA's interim parallel scientific advice program especially useful for biologic drug developers completing market authorization activities in EU member states.
Suspension Cell Culture In Cell And Gene Therapy
Adaptability is crucial for developers as they upscale the production of viral vectors. Explore the benefits of using suspension cell lines and why adherent cell culture shouldn’t be left behind.
Critical Considerations For Buffer Preparation
When optimizing your organization's buffer use, learn about the steps of buffer development, choosing a supply approach and strategy, choosing between in-house and outsourcing buffer activities, and more.
Move Your Gene Therapy From Strategy To Reality
Implementing integrated solutions can provide cell and gene therapy manufacturing systems that work in concert to create a closed, automated, scalable, and performance-qualified network of unit operations.
LIFE SCIENCE LEADER MAGAZINE
Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.
|Connect With Cell & Gene:|